Neuroblastoma surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
* Surgical intervention alone may be curative as a single therapeutic modality for the management of '''low risk''' neuroblastoma patients.
* Surgical intervention alone may be curative as a single therapeutic modality for the management of '''low risk''' neuroblastoma patients.
* Surgical intervention must be followed by chemotherapy for the management of '''intermediate risk''' neuroblastoma patients.
* Surgical intervention must be followed by chemotherapy for the management of '''intermediate risk''' neuroblastoma patients.
* The potential benefit of aggressive surgical approaches to achieve complete tumor resection in '''high-risk''' patients with metastatic disease has not been clearly demonstrated.<ref name="gov">Neuroblastoma treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#section/_1 Accessed on October, 8 2015</ref>
* The potential benefit of aggressive surgical approaches to achieve complete tumor resection in '''high-risk''' patients with metastatic disease has not been clearly demonstrated.<ref name="gov">Neuroblastoma treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#section/_1 Accessed on October, 8 2015</ref><ref>{{Cite journal
| author = [[Valeria Smith]] & [[Jennifer Foster]]
| title = High-Risk Neuroblastoma Treatment Review
| journal = [[Children (Basel, Switzerland)]]
| volume = 5
| issue = 9
| year = 2018
| month = August
| doi = 10.3390/children5090114
| pmid = 30154341
}}</ref>
* Surgical complications following neuroblastoma resection may include:<ref>Neuroblastomas. Patient (2015) http://patient.info/doctor/neuroblastomas Accessed on October, 11 2015</ref>
* Surgical complications following neuroblastoma resection may include:<ref>Neuroblastomas. Patient (2015) http://patient.info/doctor/neuroblastomas Accessed on October, 11 2015</ref>
:* Intussusception
:* Intussusception

Revision as of 14:36, 28 February 2019

Neuroblastoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neuroblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neuroblastoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neuroblastoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neuroblastoma surgery

CDC on Neuroblastoma surgery

Neuroblastoma surgery in the news

Blogs on Neuroblastoma surgery

Directions to Hospitals Treating Neuroblastoma

Risk calculators and risk factors for Neuroblastoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]Haytham Allaham, M.D. [3]

Overview

Surgery

  • Surgical intervention alone may be curative as a single therapeutic modality for the management of low risk neuroblastoma patients.
  • Surgical intervention must be followed by chemotherapy for the management of intermediate risk neuroblastoma patients.
  • The potential benefit of aggressive surgical approaches to achieve complete tumor resection in high-risk patients with metastatic disease has not been clearly demonstrated.[1][2]
  • Surgical complications following neuroblastoma resection may include:[3]
  • Intussusception
  • Internal haemorrhage due to vessel injuries
  • Nerve injuries

References

  1. Neuroblastoma treatment–for health professionals. National Cancer Institute (2015) http://www.cancer.gov/types/neuroblastoma/hp/neuroblastoma-treatment-pdq#section/_1 Accessed on October, 8 2015
  2. Valeria Smith & Jennifer Foster (2018). "High-Risk Neuroblastoma Treatment Review". Children (Basel, Switzerland). 5 (9). doi:10.3390/children5090114. PMID 30154341. Unknown parameter |month= ignored (help)
  3. Neuroblastomas. Patient (2015) http://patient.info/doctor/neuroblastomas Accessed on October, 11 2015


Template:WikiDoc Sources